Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at OPM.gov.

Transforming the understanding
and treatment of mental illnesses.

Home  |  Help for Mental Illnesses

Menu

Confidental Disclosure Agreements

When to Use Confidential Disclosure Agreements

A CDA (Confidential Disclosure Agreement) is used to assure that a party receiving proprietary information (for example, "trade secrets") will maintain the information without disclosing it to others or using it in an unauthorized manner

CDAs are frequently used in negotiating: (a) Cooperative Research and Development Agreements (CRADAs) and (b) the licensing of patent-pending technology.

Importantly, a CDA is not used to transfer biological materials. Rather, biological materials require that a Material Transfer Agreement (MTA) be in place. Scientists who are planning on transferring confidential information to non-NIMH party, or who anticipate receiving a CDA from such a party, should contact the NIMH Technology Transfer Office promptly for assistance.

Disclaimer

We link to external websites for informational purposes only, but we do not endorse or guarantee their accuracy. Once you leave our site, you will be subject to the new website’s privacy policy. Read NIMH’s full external linking policy for more information.